Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT

NCT01968239 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Branch Retinal Vein Occlusion

Interventions

DRUG: Ranibizumab

Sponsor

University of Leipzig